JPS599539B2 - ニトログリセリン水溶液及びその製造法 - Google Patents
ニトログリセリン水溶液及びその製造法Info
- Publication number
- JPS599539B2 JPS599539B2 JP54146011A JP14601179A JPS599539B2 JP S599539 B2 JPS599539 B2 JP S599539B2 JP 54146011 A JP54146011 A JP 54146011A JP 14601179 A JP14601179 A JP 14601179A JP S599539 B2 JPS599539 B2 JP S599539B2
- Authority
- JP
- Japan
- Prior art keywords
- nitroglycerin
- aqueous solution
- adsorbent
- present
- storage stability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 title claims description 43
- 239000000006 Nitroglycerin Substances 0.000 title claims description 41
- 229960003711 glyceryl trinitrate Drugs 0.000 title claims description 41
- 239000007864 aqueous solution Substances 0.000 title claims description 20
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 235000010355 mannitol Nutrition 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 8
- 229930195725 Mannitol Natural products 0.000 claims description 8
- 239000000594 mannitol Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 229960002920 sorbitol Drugs 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- 229960001855 mannitol Drugs 0.000 claims description 4
- 239000003463 adsorbent Substances 0.000 description 16
- 238000002347 injection Methods 0.000 description 13
- 239000007924 injection Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 238000004880 explosion Methods 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002360 explosive Substances 0.000 description 3
- 230000001698 pyrogenic effect Effects 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010007522 Cardiac asthma Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000004327 Paroxysmal Dyspnea Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000004004 anti-anginal agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP54146011A JPS599539B2 (ja) | 1979-11-13 | 1979-11-13 | ニトログリセリン水溶液及びその製造法 |
| US06/203,142 US4323577A (en) | 1979-11-13 | 1980-11-03 | Aqueous solution of nitroglycerin |
| GB8035907A GB2062467B (en) | 1979-11-13 | 1980-11-07 | Aqueous solution of nitroglycerin |
| CA000364363A CA1163199A (en) | 1979-11-13 | 1980-11-10 | Aqueous solution of nitroglycerin |
| DE19803042332 DE3042332A1 (de) | 1979-11-13 | 1980-11-10 | Waessrige nitroglycerinloesung |
| IT50122/80A IT1147022B (it) | 1979-11-13 | 1980-11-11 | Soluzione acquosa di nitroglicerina |
| FR8024070A FR2469178A1 (fr) | 1979-11-13 | 1980-11-12 | Solution aqueuse de nitroglycerine et composition pharmaceutique renfermant cette solution |
| ES496747A ES496747A0 (es) | 1979-11-13 | 1980-11-12 | Un metodo para preparar una solucion acuosa de nitrogliceri-na |
| DK482180A DK161186C (da) | 1979-11-13 | 1980-11-12 | Fremgangsmaade til fremstilling af en opbevaringsstabil vandig oploesning af nitroglycerin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP54146011A JPS599539B2 (ja) | 1979-11-13 | 1979-11-13 | ニトログリセリン水溶液及びその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5671046A JPS5671046A (en) | 1981-06-13 |
| JPS599539B2 true JPS599539B2 (ja) | 1984-03-03 |
Family
ID=15398067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54146011A Expired JPS599539B2 (ja) | 1979-11-13 | 1979-11-13 | ニトログリセリン水溶液及びその製造法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4323577A (en, 2012) |
| JP (1) | JPS599539B2 (en, 2012) |
| CA (1) | CA1163199A (en, 2012) |
| DE (1) | DE3042332A1 (en, 2012) |
| DK (1) | DK161186C (en, 2012) |
| ES (1) | ES496747A0 (en, 2012) |
| FR (1) | FR2469178A1 (en, 2012) |
| GB (1) | GB2062467B (en, 2012) |
| IT (1) | IT1147022B (en, 2012) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1163561A (en) * | 1979-11-06 | 1984-03-13 | Cyril Boroda | Preparation containing nitroglycerine and optionally other medicaments and preparation thereof |
| DE3109783C2 (de) * | 1981-03-13 | 1987-04-02 | Schwarz GmbH, 4019 Monheim | Verfahren zur Herstellung einer ethanolfreien Nitroglycerinlösung mit einer Konzentration von etwa 1 mg Nitroglycerin/ml |
| DE3237284A1 (de) * | 1982-10-08 | 1984-04-12 | G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt | Loesungsvermittlerfreie, waessrige nitroglycerinloesung |
| JPH0653658B2 (ja) * | 1984-12-17 | 1994-07-20 | 中外製薬株式会社 | 安定な錠剤の製造法 |
| JPH0665647B2 (ja) * | 1985-06-12 | 1994-08-24 | 株式会社三和化学研究所 | 移植皮膚処置剤 |
| KR950010150B1 (ko) * | 1986-01-14 | 1995-09-11 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 함유 주사제의 안정화 방법 |
| KR940000232B1 (ko) * | 1986-01-17 | 1994-01-12 | 쥬우가이세이야꾸 가부시끼가이샤 | 니코란딜 제제의 안정화 방법 |
| FI871447A7 (fi) * | 1986-04-07 | 1987-10-08 | Bristol Myers Co | Stabila injicerbara antivomitiva kompositioner. |
| US4882356A (en) * | 1987-03-10 | 1989-11-21 | Nassar Munir N | Stable injectable antiemetic compositions |
| US4816568A (en) * | 1986-05-16 | 1989-03-28 | International Minerals & Chemical Corp. | Stabilization of growth hormones |
| US5001151A (en) * | 1987-08-11 | 1991-03-19 | Fujisawa Usa, Inc. | Aqueous nitroglycerin injection and manufacturing process |
| US4879308A (en) * | 1987-08-11 | 1989-11-07 | Lyphomed, Inc. | Aqueous nitroglycerin injection and manufacturing process |
| JPH0645538B2 (ja) * | 1987-09-30 | 1994-06-15 | 日本化薬株式会社 | ニトログリセリンスプレー剤 |
| DE4026072A1 (de) * | 1990-08-17 | 1992-02-20 | Sanol Arznei Schwarz Gmbh | Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray |
| ES2059264B1 (es) * | 1992-11-05 | 1995-06-16 | Berrazueta Fernandez Jose Ramo | Utilizacion de los nitrovasodilatadores en la preparacion de medicamentos antiinflamatorios y analgesicos de uso topico. |
| DE59609627D1 (de) | 1995-06-27 | 2002-10-10 | Boehringer Ingelheim Pharma | Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole |
| JO2735B1 (en) * | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formations of balloonosterone |
| DE202008007318U1 (de) * | 2008-03-14 | 2008-07-31 | G. Pohl-Boskamp Gmbh & Co. Kg | Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat |
| EP2467128B1 (en) | 2010-08-03 | 2016-04-13 | G. Pohl-Boskamp GmbH & Co. KG | Use of glyceryl trinitrate for treating traumatic edema |
| WO2012113564A1 (en) | 2011-02-25 | 2012-08-30 | G. Pohl-Boskamp Gmbh & Co. Kg | Stabilized granules containing glyceryl trinitrate |
| US9248099B2 (en) | 2012-05-31 | 2016-02-02 | Desmoid Aktiengesellschaft | Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| ES2617494T3 (es) | 2012-05-31 | 2017-06-19 | G. Pohl-Boskamp Gmbh & Co. Kg | Inducción de arteriogénesis con un donador de óxido nítrico tal como nitroglicerina |
| EP2878310B1 (en) | 2013-11-29 | 2017-01-11 | G. Pohl-Boskamp GmbH & Co. KG | Sprayable aqueous composition comprising glyceryl trinitrate |
| CN116251057B (zh) * | 2022-12-29 | 2024-06-07 | 平光制药股份有限公司 | 一种硝酸异山梨酯注射液及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE632504A (en, 2012) * | 1962-05-24 | |||
| CH513760A (it) | 1970-10-14 | 1971-10-15 | I B Anstalt | Impianto automatico di caricamento di fardelli di formato uniforme su veicoli |
| DE2301664C3 (de) | 1973-01-13 | 1979-07-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Oral verabreichbares, Nitroglycerin enthaltendes Arzneimittel |
| JPS5138412A (en) * | 1974-09-24 | 1976-03-31 | Nippon Kayaku Kk | Kokoseizai no seiho |
-
1979
- 1979-11-13 JP JP54146011A patent/JPS599539B2/ja not_active Expired
-
1980
- 1980-11-03 US US06/203,142 patent/US4323577A/en not_active Expired - Lifetime
- 1980-11-07 GB GB8035907A patent/GB2062467B/en not_active Expired
- 1980-11-10 DE DE19803042332 patent/DE3042332A1/de active Granted
- 1980-11-10 CA CA000364363A patent/CA1163199A/en not_active Expired
- 1980-11-11 IT IT50122/80A patent/IT1147022B/it active
- 1980-11-12 DK DK482180A patent/DK161186C/da active
- 1980-11-12 FR FR8024070A patent/FR2469178A1/fr active Granted
- 1980-11-12 ES ES496747A patent/ES496747A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2469178B1 (en, 2012) | 1983-12-23 |
| FR2469178A1 (fr) | 1981-05-22 |
| US4323577A (en) | 1982-04-06 |
| DK161186B (da) | 1991-06-10 |
| ES8201419A1 (es) | 1981-11-16 |
| IT8050122A0 (it) | 1980-11-11 |
| JPS5671046A (en) | 1981-06-13 |
| IT1147022B (it) | 1986-11-19 |
| DE3042332C2 (en, 2012) | 1988-08-25 |
| DE3042332A1 (de) | 1981-05-21 |
| GB2062467A (en) | 1981-05-28 |
| DK161186C (da) | 1991-11-25 |
| DK482180A (da) | 1981-05-14 |
| ES496747A0 (es) | 1981-11-16 |
| CA1163199A (en) | 1984-03-06 |
| GB2062467B (en) | 1983-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS599539B2 (ja) | ニトログリセリン水溶液及びその製造法 | |
| US4754597A (en) | Solid shaped articles | |
| JP5144527B2 (ja) | 改良された安定性と生物学的利用能をもつ塩酸パロノセトロンの投与形態 | |
| KR20120102585A (ko) | 신속 용해 고체 투약 제형 | |
| JP5334937B2 (ja) | ビノレルビンを含むソフトカプセルのための経口製薬組成物及び治療方法 | |
| WO2014076680A1 (en) | Solid dosage form comprising micronized cytisine | |
| JP2005529133A (ja) | 心・脳血管病および眼底病の治療のための漢方薬注射剤ならびにその製造方法 | |
| JP2624396B2 (ja) | ニトログリセリンエアゾールスプレー | |
| US2830010A (en) | Powder-filled hexylresorcinol capsules | |
| CN102309441B (zh) | 一种水飞蓟宾药物组合包装物及其制备方法 | |
| US3326760A (en) | Choline salicylate polygalacturonate therapy | |
| JPH0278613A (ja) | 精油含有軟カプセル | |
| US4829057A (en) | Oxytetracycline capsules with increased stability and methds of producing the same | |
| US3873727A (en) | Stabilization of molded sublingual nitroglycerin tablets | |
| JPS6140647B2 (en, 2012) | ||
| KR101832562B1 (ko) | 콜린 알포세레이트와 커큐민의 공결정 제조방법 | |
| DE60122384T2 (de) | Verfahren zur herstellung einer beständige pharmazeutische form von paclitaxel | |
| JPS60209516A (ja) | エトポシド経口剤形組成物 | |
| CN114432240A (zh) | 一种稳定不刺激的酮咯酸氨丁三醇注射液及其制备方法 | |
| CN102552210B (zh) | 一种恩替卡韦胶囊组合物及其制备方法 | |
| US3350270A (en) | Aluminum aspirin film-enveloped therapeutic agents in sustained release dosage form | |
| US2799617A (en) | Piperazine adipate compositions and treatment of helminth infections therewith | |
| JPH0219804B2 (en, 2012) | ||
| JPS629096B2 (en, 2012) | ||
| RU2240797C1 (ru) | Усовершенствованная водорастворимая форма теофиллина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |